DAPAGLIFLOZIN 5 MG TABLET

DAPAGLIFLOZIN
$11.4600per EA

Strength

5 mg/1

NDC

66993045630

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DAPAGLIFLOZIN PROPANEDIOL

Approval Type

Authorized Generic (NDA)

FDA Application

NDA202293

On Market Since

1/3/2024

Pharmacological Classes

Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

-0.3%

3M

+0.2%

6M

-0.1%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

+0.0%